Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Gonal f vs follistim?Deferasirox synthesis?Immunotherapy opdivo?Methscopolamine discount?Capecitabine price philippines?
See the DrugPatentWatch profile for Rybrevant
Rybrevant (amivantamab) 2023 sales are reported at about $1.5 billion (approximately $1,500 million). [1] Sources: [1] https://drugpatentwatch.com/p/rybrevant-sales-2023
Other Questions About Rybrevant :